Aurobindo Pharma
AUROPHARMANSE

Aurobindo Pharma

₹1,622.10-41.30 (2.48%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
F&O

Performance

Today’s low
1,621.90
Today’s high
1,670.00
52 week low
1,016.10
52 week high
1,682.40
Open price
1,662.40
Previous close
1,663.40
Live volume
8,24,842
Lower circuit
1,497.10
Upper circuit
1,829.70

Fundamentals

Market Cap
₹96,216Cr
ROE
9.25%
P/E Ratio(TTM)
25.93
EPS(TTM)
63.89
P/B Ratio
2.54
Dividend Yield
0.24%
Industry P/E
37.43
Book Value
652.39
Debt to Equity
0.21
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹9,415
+4.95%
Profit (Cr)
₹1,032
+12.07%
02.5k5k7.5k10k
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)+18%
3Y CAGR+11%
Profit growthValue
1Y (TTM)+25%
3Y CAGR+22%

About

Aurobindo Pharma is a well-integrated global pharmaceutical firm committed to providing affordable and accessible medicines to patients around the globe. The company's vision is to become a leading and admired global pharmaceutical player, aiming to be ranked within the top 25 companies by the year 2030. Its mission focuses on being the most valued partner to the pharma industry by continuously developing and manufacturing products that meet the highest regulatory standards. The company develops and commercializes a diverse portfolio including generics, specialty products, injectables, active pharmaceutical ingredients, biosimilars, and vaccines across 150+ countries. Leveraging its expertise in large-scale production, the company has positioned itself as a cost-effective provider of Active Pharmaceutical Ingredients (API) for its own and external needs. As the 2nd largest listed Indian pharma company by revenue from operations, it has successfully established itself as a key player in the global market.;
CEO/MD
K Nityananda Reddy
Founded in
1986
NSE symbol
AUROPHARMA

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹1,930.00
-2.00 (0.10%)
L
    H
    4,66,154.7938.475.58
    ₹4,833.00
    -81.50 (1.66%)
    L
      H
      1,85,478.7886.0322.06
      CiplaCIPLA
      ₹1,450.00
      -8.80 (0.60%)
      L
        H
        1,18,027.3535.173.43
        LupinLUPIN
        ₹2,235.00
        -15.30 (0.68%)
        L
          H
          1,03,380.2818.624.61
          Livesquawk
          Aurobindo Pharma's subsidiary, Eugia Pharma, received a US FDA warning letter. The unit contributes 2% of total revenue; US supplies remain unaffected.
          Livesquawk
          Citi maintains Sell on Aurobindo Pharma with a ₹1,260 target due to weak 4-5% constant-currency growth. 1QFY27 slightly beat estimates due to lower R&D and favorable currency; US growth challenges persist.
          Livesquawk
          Bernstein maintains Market Perform on Aurobindo Pharma with a target price of ₹1,498. Q1 shows steady growth, but US ex-Lannett declined 3% with slower product approvals.
          2026
          5
          Aug
          Quarterly Result
          Release date
          21
          May
          Annual Result
          Release date

          17
          Apr
          Buyback
          Ex date

          Offer price₹1,475.00
          Buyback window23 Apr ‘26 to 29 Apr ‘26
          Ex date17 Apr ‘26
          Record date17 Apr ‘26
          Announcement date6 Apr ‘26
          Buyback typeTender Offer

          6
          Apr
          Buyback
          Announced

          Offer price₹1,475.00
          Buyback window23 Apr ‘26 to 29 Apr ‘26
          Ex date17 Apr ‘26
          Record date17 Apr ‘26
          Announcement date6 Apr ‘26
          Buyback typeTender Offer
          9
          Feb
          Quarterly Result
          Release date
          2025
          5
          Nov
          Quarterly Result
          Release date

          8
          Aug
          Dividend
          Ex date
          ₹4.00
          per share

          For each share you hold, you will receive ₹4.00
          Dividend amount₹4.00 per share
          Dividend TypeInterim
          Ex Date8 Aug ‘25
          Record Date8 Aug ‘25
          Announcement date4 Aug ‘25

          4
          Aug
          Dividend
          Announced
          ₹4.00
          per share

          For each share you hold, you will receive ₹4.00
          Dividend amount₹4.00 per share
          Dividend TypeInterim
          Ex Date8 Aug ‘25
          Record Date8 Aug ‘25
          Announcement date4 Aug ‘25
          4
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks